Bills · S 2842
IN COMMITTEE· 119TH CONGRESS
Senate BillS 2842Health
Stop CMV Act of 2025
INTRO SEP 17· LAST ACTION SEP 17
READING
4MIN
COSPONSORS
4BIPARTISAN
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenThis bill matters because congenital Cytomegalovirus (CMV) is a leading cause of birth defects and childhood disability, but many parents are unaware of it. Currently, universal CMV screening for newborns isn't widespread, meaning many cases go undetected until symptoms appear, sometimes leading to irreversible hearing loss, developmental delays, or other severe health problems.
If this bill becomes law, it could lead to more widespread optional screening, allowing for earlier identification of affected infants. This early detection enables timely medical interventions, which can significantly improve long-term health outcomes and reduce the severity of disabilities associated with CMV. Without this bill, CMV screening will likely remain inconsistent across states, potentially delaying diagnosis and treatment for many vulnerable infants.
KEY PROVISIONS
5AI-extractedPROVISION 01
Allows hospitals and healthcare facilities to administer congenital Cytomegalovirus (CMV) tests to infants 21 days or less of age.
This provision makes optional CMV screening a formal possibility for newborns, potentially leading to earlier detection of the virus.
PROVISION 02
Permits states to prescribe standards and procedures for CMV testing, tracking, follow-up, and disseminating information to parents.
It establishes a framework for states to create consistent, organized screening programs and ensures parents are informed about testing.
PROVISION 03
Authorizes federal grants through HRSA to states that implement CMV screening programs, and through CDC for data collection and public education.
These grants provide financial support to states, incentivizing them to establish or improve their CMV screening and awareness efforts.
PROVISION 04
Directs the National Institutes of Health (NIH) to establish or expand research programs on new CMV screening techniques, diagnostics, prevention, treatments, and vaccine development.
This accelerates scientific efforts to improve how CMV is detected, prevented, and treated, potentially leading to better outcomes in the future.
PROVISION 05
Requires the Discretionary Advisory Committee on Heritable Disorders in Newborns and Children to review and approve state standards, and prescribe standards if a state fails to do so within two years.
This ensures a level of federal oversight and consistency, providing a safety net if states do not develop their own screening protocols.
SPONSORSHIP
1 + 4
D· Connecticut
YRS IN OFFICE
15
BILLS LED
128
COSPONSOR BREAKDOWNBIPARTISAN · 50%
DEM 3 REP 1 IND 0
ACTION TIMELINE
2 EVENTSSEP 17
Introduced in Senate
SEP 17
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
BILL INFO
TypeSenate Bill
NumberS 2842
Congress119th
StatusIn Committee
IntroducedSep 17, 2025
Last actionSep 17, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · HEALTH, EDUCATION, LABOR, AND PENSIONS COMMITTEE · INTRODUCED SEP 17, 2025
Senate BillS 2842Health
Stop CMV Act of 2025
INTRODUCED SEP 17, 2025· LAST ACTION SEP 17, 2025
PASSAGE CHANCES
—%
READING
4 min
COSPONSORS
4
COMPLEXITY
Moderate
